
    
      Single dose escalation study of 5 dose levels of VBY-376. Eight subjects per group will
      receive one dose of VBY-376 then have multiple blood draws for pharmacokinetic evaluation and
      followed for safety with laboratory evaluations, ECG's, vital signs, and adverse events.
      Safety data will be reviewed before proceeding to the next dose.
    
  